OUP (Osage University Partners) Founded 2009
Founders Robert Adelson
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 66
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 66
Rounds per year 5.50
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.43
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Seed
Areas of investment
Biotechnology
Finance
Financial Services
Medical Device
Pharmaceutical
Venture Capital
Summary

In 2009 was created OUP (Osage University Partners), which is appeared as VC. The main office of represented VC is situated in the Bala Cynwyd. The fund was located in North America if to be more exact in United States.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Artificial Intelligence. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Receptos, Cardioxyl Pharmaceuticals, Guardant Health.

This organization was formed by Robert Adelson. We also calculated 5 valuable employees in our database.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2017. The real fund results show that this VC is 16 percentage points less often commits exit comparing to other companies. The typical startup value when the investment from OUP (Osage University Partners) is 50-100 millions dollars. The fund is constantly included in 7-12 deals per year. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Opposing the other organizations, this OUP (Osage University Partners) works on 9 percentage points less the average amount of lead investments.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the OUP (Osage University Partners), startups are often financed by OrbiMed, BioAdvance, Sutter Hill Ventures. The meaningful sponsors for the fund in investment in the same round are Sutter Hill Ventures, The Column Group, HBM Healthcare Investments AG. In the next rounds fund is usually obtained by General Catalyst, Lux Capital, OrbiMed.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Clarifai
Artificial Intelligence
Computer Vision
Developer APIs
Enterprise
Image Recognition
Machine Learning
Software
Visual Search
Series A
10M28 Apr 2015 United States, New York
Corridor Pharmaceuticals
Biotechnology
Health Care
Therapeutics
Series A
13M24 Jun 2010 United States, Towson
ESCAPE Bio
Biotechnology
Health Care
Medical
Venture - Series Unknown
73M14 Sep 2020 United States, South San Francisco
Perceptive Automata
Artificial Intelligence
Automotive
Autonomous Vehicles
Machine Learning
Robotics
Transportation
Seed
3M10 Jul 2017 United Kingdom, Boston
Aptinyx
Biopharma
Biotechnology
Health Care
Medical
Series B
70M18 Dec 2017 United States, Evanston
Iconic Therapeutics
Biopharma
Biotechnology
Drug Discovery
Therapeutics
Venture - Series Unknown
4M15 Jun 2018 United States, South San Francisco
MC10
Electronics
Semiconductor
Wearables
Venture - Series Unknown
10M20 Aug 2018 United States, Lexington
Algorithmia
Artificial Intelligence
Cloud Computing
Developer Tools
Machine Learning
SaaS
Software
Software Development Applications
Seed
2M18 Aug 2014 United States, Seattle
Biohaven Pharmaceutical
Biotechnology
Health Care
Health Diagnostics
Neuroscience
Pharmaceutical
Venture - Series Unknown
80M01 Nov 2016 United States, New Haven
Arrakis Therapeutics
Biopharma
Biotechnology
Medical
Pharmaceutical
Series A
38M27 Feb 2017 United States, Waltham
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent OUP (Osage University Partners)?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: